<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PZIJ8AAW</identifier><date>2015</date><creator>Locatelli, Igor</creator><creator>Petrovič, Maja</creator><relation>documents/doc/P/URN_NBN_SI_doc-PZIJ8AAW_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PZIJ8AAW_001.txt</relation><format format_type="issue">5</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 414-422</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">4007025</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PZIJ8AAW</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antagonisti endotelinskih receptorjev</subject><subject language_type_id="slv">pljučna arterijska hipertenzija</subject><subject language_type_id="slv">primerno zdravljenje</subject><subject language_type_id="slv">prostaciklin</subject><subject language_type_id="slv">specifična zdravila</subject><subject language_type_id="slv">uporaba zdravil</subject><title>Medicines used in the treatment of pulmonary arterial hypertension</title><title>Zdravila za zdravljenje pljučne arterijske hipertenzije</title></Record>